Medical Education Division
Our Products
On-Line Store

Google
 
Web www.brooksidepress.org

Operational Medicine 2001
Hydralazine (Apresoline)

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

 
 

Category:

  • Miscellaneous

Description:

  • Antihypertensive; (preferentially dilates arterioles)

Indications:

  • Hypertension

Contraindications:

  • Coronary artery disease

  • Valvular rheumatic heart disease

Precautions:

  • Pregnancy category C

  • Advanced renal disease, children, pulmonary hypertension

Adverse Reactions (Side Effects):

  • CNS: anxiety, dizziness, headache, peripheral neuritis, psychotic reactions, tremor

  • CV: angina, edema, flushing, hypotension, palpitations, reflex tachycardia

  • EENT: nasal congestion

  • GI: anorexia, constipation, diarrhea, hepatitis, paralytic ileus, nausea, vomiting

  • GU: urination difficulty

  • HEME: agranulocytosis, anemia, eosinophilia, leukopenia

  • SKIN: pruritis, rash, urticaria

  • MISC: lupus-like syndrome, arthralgia, muscle cramps

Dosage:

Administered orally (tablet), intramuscularly, and intravenously

  • Adult:   

    • PO 10mg 4 times daily, increase by 10-25 mg/dose every 2-5 days as needed to max of 300 mg/day

    • IM/IV 10-20mg every 4-6 hours, may increase to 40 mg/dose

  • Child:   

    • PO 0.75-1 mg/kg/day divided 2-4 times daily, increase over 3-4 weeks to 7.5 mg/kg/day divided 2-4 times daily if necessary, do not exceed 200 mg/day

    • IM/IV 0.1-0.2 mg/kg/dose every 4-6 hours, do not exceed 20 mg/dose

Special Considerations:

  • May cause black stools

  •  Take with meals

  •  Lupus-like syndrome more common in “slow acetylators” and folling higher doses for prolonged periods

  •  Patient to notify clinician of any unexplained prolonged general tiredness, or fever, muscle or joint aching, or chest pain


Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001

Health Care in Military Settings

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products